cefuroxim sandoz 125mg compresse rivestite con film
sandoz pharmaceuticals ag - cefuroximum - compresse rivestite con film - cefuroximum 125 mg ut cefuroximum axetili, natrii laurilsulfas, copovidonum, carmellosum natricum conexum, magnesii stearas, silica colloidalis anhydrica, mannitolum, cellulosum microcristallinum, crospovidonum, talcum, Überzug: mannitolum, amylodextrinum, talcum, aspartamum 0.2 mg, e 171 pro compresso obducto corresp. natrium 2.66 mg. - malattie infettive - synthetika
linezolid pfizer 2 mg/mi lnfusionslösung
pfizer ag - linezolidum - lnfusionslösung - linezolidum 2 mg, natrii citras dihydricus corresp. natrium 0.38 mg, acidum citricum, glucosum monohydricum corresp. glucosum 45.7 mg, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - malattie infettive - synthetika
linezolid pfizer 600 mg compresse rivestite con film
pfizer ag - linezolidum - compresse rivestite con film - linezolidum 600 mg, maydis amylum, cellulosum microcristallinum, hydroxypropylcellulosum, carboxymethylamylum natricum a corresp. natrium max. 3.4 mg, magnesii stearas, Überzug: cera carnauba, hypromellosum, e 171, macrogolum 400, pro compresso obducto. - malattie infettive - synthetika
alges-x l compresse rivestite con film
axapharm ag - ibuprofenum - compresse rivestite con film - ibuprofenum 200 mg ut ibuprofenum lysinum 342 mg, cellulosum microcristallinum, copovidonum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, talcum, Überzug: hypromellosum, polydextrosum, talcum, maltodextrinum, triglycerida media, e 110 0.018 mg, e 124 0.0495 mg, e 132, e 171, carmellosum natricum, maltodextrinum, glucosum monohydricum 1.064 mg, kalii aluminii silicas, e 171, lecithinum ex soja, pro compresso obducto corresp. natrium 0.31 mg. - analgesico - synthetika
emge biomed polvere per la preparazione di una soluzione orale
biomed ag - magnesio - polvere per la preparazione di una soluzione orale - magnesium 300 mg ut magnesii citras 1931.745 mg, aurantii fructus siccatus cum fructosum ca. 0.1 g et glucosum ca. 0.1 g et saccharum ca. 0.1 g, maltodextrinum, acidum citricum, kalii hydrogenocarbonas, aromatica (orange), aromatica (zitrone), natrii cyclamas, saccharinum natricum, e 160(a), e 307, natrii ascorbas, triglycerida media, acaciae gummi, saccharum, maltodextrinum, silica colloidalis hydrica, ad granulatum pro charta 4 g corresp. kalium 78 mg et natrium 5.5 mg. - magnesio prodotto - synthetika
mutaflor capsule
om pharma suisse sa - escherichia coli viva (souche: nissle 1917) - capsule - escherichia coli viva (souche: nissle 1917) 2.5-25 u. mia, maltodextrinum, glycerolum 3.09-15.47 mg, talco, macrogolum 4000, triethylis citras, acidi methacrylici e methylis methacrylatis polymerisatum 1:1, lacca, cera bianca, cera carnauba, e 171, e 172 (giallo), per la capsula, matériel de la capsula: gelatina, acqua purificata. - la colite ulcerosa in fase di remissione - batteri e hefepräparate
mutaflor mite capsule
om pharma suisse sa - escherichia coli viva (souche: nissle 1917) - capsule - escherichia coli viva (souche: nissle 1917) 0.5-5 u. mia, maltodextrinum, glycerolum 1.24-6.19 mg, talco, macrogolum 4000, triethylis citras, acidi methacrylici e methylis methacrylatis polymerisatum 1:1, lacca, cera bianca, cera carnauba, e 171, e 172 (giallo), per la capsula, matériel de la capsula: gelatina, acqua purificata. - la colite ulcerosa in fase di remissione - batteri e hefepräparate
dukoral suspension und brausegranulat zur herstellung einer suspension zum einnehmen
bavarian nordic switzerland ag - vibrio cholerae o1 inaba 6973 biotipus el tor inactivatus (formaldehydum), vibrio cholerae o1 inaba 48 classical biotyp inactivatus (calor), vibrio cholerae o1 ogawa 50 classical biotyp inactivatus (calor), vibrio cholerae o1 ogawa 50 classical biotyp inactivatus (formaldehydum), toxinum cholerae subunitatis b recombinatum (rctb-213) - suspension und brausegranulat zur herstellung einer suspension zum einnehmen - vaccinum attenuatum per os: vibrio cholerae o1 inaba 6973 biotipus el tor inactivatus (formaldehydum) 31.25 mia. u., vibrio cholerae o1 inaba 48 classical biotyp inactivatus (calor) 31.25 mia. u., vibrio cholerae o1 ogawa 50 classical biotyp inactivatus (calor) 31.25 mia. u., vibrio cholerae o1 ogawa 50 classical biotyp inactivatus (formaldehydum) 31.25 mia. u., toxinum cholerae subunitatis b recombinatum (rctb-213) 1 mg, natrii chloridum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, aqua ad iniectabile, q.s. ad suspensionem pro 3 ml. granulat: natrii hydrogenocarbonas, acidum citricum, aromatica cum maltodextrinum, saccharinum natricum, natrii carbonas, natrii citras dihydricus, ad granulatum pro 5.6 g. suspensio reconstituta: suspensio reconstituta corresp. natrium ca. 1.2 g. - aktive immunisierung gegen cholera und etec-diarrhoe ab dem 2. geburtstag - vaccini
tardyferon retardtabletten
pierre fabre pharma sa - ferro(ii) - retardtabletten - ferrum(ii) 80 mg ut ferrosi sulfas desiccatus, maltodextrinum, cellulosum microcristallinum, ammonio methacrylatis copolymerum a, ammonio methacrylatis copolymerum b, triethylis citras, talcum, glyceroli dibehenas, Überzug: hypromellosum, cellulosum microcristallinum, acidum stearicum, triethylis citras, e 172 (rubrum), e 172 (flavum), e 171, pro compresso obducto. - anemia da carenza di ferro in caso di accertata carenza di ferro - synthetika
gyno-tardyferon retardtabletten
pierre fabre pharma sa - di ferro(ii), acido-folicum - retardtabletten - ferrum(ii) 80 mg ut ferrosi sulfas desiccatus, acidum folicum 0.35 mg, maltodextrinum, cellulosum microcristallinum, ammonio methacrylatis copolymerum a, ammonio methacrylatis copolymerum b, talcum, triethylis citras, glyceroli dibehenas, Überzug: hypromellosum, cellulosum microcristallinum, acidum stearicum, triethylis citras, e 171, e 172 (flavum), e 172 (rubrum) pro compresso obducto. - di ferro e di presentare carenze di acido folico in gravidanza e allattamento - synthetika